Health Trials

About this trial

In this prospective, randomized, split-body control trial, we aim to compare complications, patient-reported outcomes, and cost differentials following reduction mammaplasty with prophylactic closed incision negative pressure wound therapy versus standard adhesive dressing.

Eligibility criteria

Qualifiers

Female patients

Age 18 years or older

Scheduled to undergo bilateral reduction mammaplasty with a Wise pattern (anchor) incision and a superomedial, inferior, or central mound pedicle at MedStar Georgetown University Hospital or MedStar Good Samaritan Hospital

Able to comply with study procedures and follow-up visits

Disqualifiers

Younger than 18 years of age

Biologically male patients

Scheduled to undergo unilateral breast mammaplasty

Currently pregnant or lactating

Trial design

Treatments tested in this trial

  • Prophylactic ciNPWT
  • Standard Adhesive Dressing

Treatment groups

92 Participants
are divided into 2 treatment groups

Locations

1
Medstar Georgetown University Hospital20007, Washington D.C.District of Columbia, United States

Sponsors and collaborators

Medstar Health Research Institute

Lead sponsor

3M

Collaborator

Source ClinicalTrials.gov